Immune Response Generated With the Administration of Autologous Dendritic Cells Pulsed With an Allogenic Tumoral Cell-Lines Lysate in Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma

Shared ACVR1 mutations in FOP and DIPG: Opportunities and challenges in extending biological and clinical implications across rare diseases

(2018) Harry J. Han et al.   BONE

Survival benefit for patients with diffuse intrinsic pontine glioma (DIPG) undergoing re-irradiation at first progression: A matched-cohort analysis on behalf of the SIOP-E-HGG/DIPG working group

(2017) Geert O. Janssens et al.   EUROPEAN JOURNAL OF CANCER

Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapy

(2017) Zinal S. Chheda et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Preliminary results of immune modulating antibody MDV9300 (pidilizumab) treatment in children with diffuse intrinsic pontine glioma

(2017) Iris Fried et al.   JOURNAL OF NEURO-ONCOLOGY

Histone H3.3K27M Represses p16 to Accelerate Gliomagenesis in a Murine Model of DIPG

(2017) Francisco J. Cordero et al.   MOLECULAR CANCER RESEARCH

Vaccine-based immunotherapeutic approaches to gliomas and beyond

(2017) Michael Weller et al.   Nature Reviews Neurology

Diffuse intrinsic pontine gliomas—current management and new biologic insights. Is there a glimmer of hope?

(2017) Kenneth J. Cohen et al.   NEURO-ONCOLOGY

Potential New Therapies for Pediatric Diffuse Intrinsic Pontine Glioma

(2017) Wenyong Long et al.   Frontiers in Pharmacology

Convection-Enhanced Delivery for Diffuse Intrinsic Pontine Glioma Treatment

(2016) Zhiping Zhou et al.   Current Neuropharmacology

Immunotherapy of Malignant Tumors in the Brain: How Different from Other Sites?

(2016) Valérie Dutoit et al.   Frontiers in Oncology

Dendritic-cell vaccines on the move

(2015) Rachel Lubong Sabado et al.   NATURE

Future Clinical Trials in DIPG: Bringing Epigenetics to the Clinic

(2015) Andres Morales La Madrid et al.   Frontiers in Oncology

Brain Tumor Immunotherapy: What have We Learned so Far?

(2015) Stefaan Willy Van Gool   Frontiers in Oncology

Histopathological spectrum of paediatric diffuse intrinsic pontine glioma: diagnostic and therapeutic implications

(2014) Pawel Buczkowicz et al.   ACTA NEUROPATHOLOGICA

Immunotherapy for Brain Cancer: Recent Progress and Future Promise

(2014) C. M. Jackson et al.   CLINICAL CANCER RESEARCH

Antigen-Specific Immune Responses and Clinical Outcome After Vaccination With Glioma-Associated Antigen Peptides and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Children With Newly Diagnosed Malignant Brainstem and Nonbrainstem Gliomas

(2014) Ian F. Pollack et al.   JOURNAL OF CLINICAL ONCOLOGY

Diffuse intrinsic pontine glioma: a reassessment

(2014) Nathan J. Robison et al.   JOURNAL OF NEURO-ONCOLOGY

Clinical use of dendritic cells for cancer therapy

(2014) Sébastien Anguille et al.   LANCET ONCOLOGY

The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma

(2014) Gang Wu et al.   NATURE GENETICS

Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations

(2014) Pawel Buczkowicz et al.   NATURE GENETICS

Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma

(2014) Kathryn R Taylor et al.   NATURE GENETICS

K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas

(2012) Dong-Anh Khuong-Quang et al.   ACTA NEUROPATHOLOGICA

Palliative Reirradiation for Progressive Diffuse Intrinsic Pontine Glioma

(2011) Hiral P. Fontanilla et al.   AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS